Nirogacestat Hydrobromide Patent Expiration
Nirogacestat Hydrobromide is Used for treating adult patients with progressing desmoid tumors. It was first introduced by Springworks Therapeutics Inc
Nirogacestat Hydrobromide Patents
Given below is the list of patents protecting Nirogacestat Hydrobromide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ogsiveo | US10590087 | Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof | Aug 09, 2039 | Springworks |
| Ogsiveo | US10710966 | Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof | Aug 09, 2039 | Springworks |
| Ogsiveo | US10941118 | Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof | Aug 09, 2039 | Springworks |
| Ogsiveo | US11504354 | Chlorinated tetralin compounds and pharmaceutical compositions | Jul 08, 2042 | Springworks |
| Ogsiveo | US11612588 | Chlorinated tetralin compounds and pharmaceutical compositions | Jul 08, 2042 | Springworks |
| Ogsiveo | US11807611 | Chlorinated tetralin compounds and pharmaceutical compositions | Sep 08, 2042 | Springworks |
| Ogsiveo | US11820748 | Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof | Aug 09, 2039 | Springworks |
| Ogsiveo | US11844780 | Chlorinated tetralin compounds and pharmaceutical compositions | Sep 08, 2042 | Springworks |
| Ogsiveo | US11845732 | Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof | Aug 09, 2039 | Springworks |
| Ogsiveo | US11872211 | Treatments with nirogacestat | May 19, 2043 | Springworks |
| Ogsiveo | US11884634 | Compositions of solid forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4- tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide | Aug 09, 2039 | Springworks |
| Ogsiveo | US11884635 | Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof | Aug 09, 2039 | Springworks |
| Ogsiveo | US11905255 | Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof | Aug 09, 2039 | Springworks |
| Ogsiveo | US11925619 | Treatments with nirogacestat | May 19, 2043 | Springworks |
| Ogsiveo | US11925620 | Treatments with nirogacestat | May 19, 2043 | Springworks |
| Ogsiveo | US11938116 | Treatments with nirogacestat | May 19, 2043 | Springworks |
| Ogsiveo | US11951096 | Treatments with nirogacestat | May 19, 2043 | Springworks |
| Ogsiveo | US11957662 | Treatments with nirogacestat | May 19, 2043 | Springworks |
| Ogsiveo | US12011434 | Treatments with nirogacestat | May 19, 2043 | Springworks |
| Ogsiveo | US12011435 | Treatments with nirogacestat | May 19, 2043 | Springworks |
| Ogsiveo | US7342118 | Imidazole compounds for the treatment of neurodegenerative disorders | Aug 18, 2025 | Springworks |
| Ogsiveo | US7795447 | Imidazole compounds for the treatment of neurodegenerative disorders | Aug 18, 2025 | Springworks |
| Ogsiveo | US7951958 | Imidazole compounds for the treatment of neurodegenerative disorders | Mar 11, 2025 | Springworks |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳